重组人脑利钠肽治疗老年患者急性心力衰竭的临床效果分析  

Clinical Efficacy of Recombinant Human Brain Natriuretic Peptide in the Treatment of Elderly Patients With Acute Heart Failure

作　　者：梁力 张勇[1] 王新宇[1] 陈青远[1] 唐小霞[1] 宗超 LIANG Li;ZHANG Yong;WANG Xinyu;CHEN Qingyuan;TANG Xiaoxia;ZONG Chao(Department of Cardiology, Xuzhou Tumor Hospital, Xuzhou Jiangsu 221000, China)

机构地区：[1]徐州市肿瘤医院心内科,江苏徐州221000

出　　处：《中国继续医学教育》2017年第35期84-85,共2页China Continuing Medical Education

摘　　要：目的分析重组人脑利钠肽治疗老年急性心力衰竭患者的临床效果。方法择取医院就医的50例老年急性心力衰竭患者,选取时间为2015年1月1日—2016年12月31日,通过随机颜色球抽取的方法将其分为两组。分别给予左西孟旦注射液、重组人脑利钠肽治疗,对比两组治疗效果、相关临床指标、心率、平均动脉压、血压情况。结果观察组治疗效果优于对照组,相关临床指标、心率、平均动脉压、血压情况与对照组相比,差异有统计学意义(P<0.05)。结论重组人脑利钠肽治疗老年急性心力衰竭患者效果显著。Objective To analyze the clinical effect of recombinant human brain natriuretic peptide in the treatment of elderly patients with acute heart failure. Methods Fifty elderly patients with acute heart failure admitted to the hospital were enrolled in this study. The selection time ranged from January 1, 2015 to December 31, 2016. The patients were divided into two groups by random color ball extraction. The patients were given levosimendan injection and recombinant human brain natriuretic peptide respectively. The therapeutic effect, relevant clinical indexes, heart rate, mean arterial pressure and blood pressure were compared between the two groups. Results The observation group had better effect than the control group. The related clinical indexes, heart rate, mean arterial pressure and blood pressure were signifcantly different from those in the control group （P 〈 0.05）. Conclusion Recombinant human brain natriuretic peptide is effective in elderly patients with acute heart failure and can be promoted.

关 键 词：重组人脑利钠肽 老年 急性心力衰竭 临床效果 分析 

分 类 号：R541[医药卫生—心血管疾病]